Clinical Characteristics and Coping Strategies of Neoplasms with 2019 Novel Coronavirus Infection

Clinical Characteristics and Coping Strategies of Neoplasms with 2019 Novel Coronavirus Infection

Nan-nan ZHAO, Jie Shi, Shuanying YANG, Lizhong Zeng

Since mid-December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken in Wuhan, Hubei Province, China, and spread rapidly to other provinces in China and dozens of countries and regions around the world, becoming the Public Health Emergency of International Concern (Public Health Emergency of International Concern). SARS-CoV-2 can mainly transmit by droplets or close contact, and is generally susceptible in the crowd. Tumor patients are at high risk of this pathogen because of their impaired immune function. Identifying tumor patients with 2019 novel coronavirus disease (COVID-19) early, and understanding its distribution characteristics can help to improve the cure rate of patients, and better control the epidemic and development of SARS-CoV-2 much better. With comprehensive analysis of relevant literature, this paper reviews the clinical characteristics of neoplastic patients with COVID-19, and puts forward some suggestions on how to deal with this epidemic.

2020

Tumor, SARS-CoV-2, 2019 novel coronavirus disease (covid-19)

DOI: 10.3779/j.issn.1009-3419.2020.102.15

Chinese Journal of Lung Cancer

Chinese Anti-Cancer Association; Chinese Antituberculosis Association

Neoplasms. Tumors. Oncology. Including cancer and carcinogens